搜索筛选:
搜索耗时0.0772秒,为你在为你在102,285,761篇论文里面共找到 4 篇相符的论文内容
发布年度:
[会议论文] 作者：NingNing Ma,Liangzhi Xie,
来源：2011第三届中国北京抗体大会 年份：2011
With multiple companies developing similar therapeutics to the same target and patent ticking toward expiration, speed is critical for therapeutic developme...
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced eso
[期刊论文] 作者：Ming Bai,Meng Wang,Ting Deng,Yuxian Bai,Kai Zang,Zhanhui Miao,Wenlin Gai,Liangzhi Xie,Yi Ba,
来源：癌症生物学与医学（英文版） 年份：2022
Objective: The mainstay treatment of esophageal squamous cell carcinoma (ESCC) involves chemotherapy and immunotherapy. However, alternative therapies are required for patients who are refractory or intolerant to existing therapies. Methods......
[期刊论文] 作者：,Jiming Yin,Xingguang Lin,Tiantian Zhang,Xiao Yao,Ying Xu,Yao Lu,Wenzhi Wang,Kun Liu,Jie Zhang,Liangzhi Xie,
来源：中国科学:生命科学英文版 年份：2021
Dear Editor,Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)has caused the global outbreak of coronavirus disease 2019(COVID-19).By far,more than 35 million people had been infected by SARS-CoV-2,resulting in more than 1 million ......
Phase I study of chimeric anti-CD20 monoclonal antibody in Chinese patients with CD20-positive non-H
[期刊论文] 作者：Yuanyuan Song,Jiarui Yao,Jianliang Yang,Peng Liu,Yan Qin,Shuxiang Zhang,Weijing Zhang,Wenlin Gai,Liangzhi Xie,
来源：Chinese Journal of Cancer Research 年份：2016
Objective: This study was designed to determine the safety, pharmacokinetics and biologic effects of a humanmouse chimeric anti-CD20 monoclonal antibody(SCT400)...
相关搜索：
